Doximity, Inc. DOCS
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Ask Irving AI About DOCS
Get to know the stock you’re researching through a simple conversation. Ask Irving about its Weiss rating, financial health, dividends, and potential risks — right from the stock page.
Get answers about this stock. Instantly.
Ask about the company’s financial health and its Weiss Safety, Reward, and Risk Ratings, with answers grounded in Weiss Ratings data.
Understand the numbers behind the rating.
Explore profits, cash flow, valuation, and dividends. Ask follow-up questions without leaving the stock page.
Put the stock’s strengths and risks in context.
Look beyond a single number. Explore rating changes and company trends to better understand the stock’s outlook.
Company Overview
Doximity, Inc. is a U.S.-based digital platform company focused on healthcare professionals. The company operates primarily in the healthcare technology and digital communications industries, providing online networking, telehealth, workflow, recruiting, and marketing tools tailored to physicians and other medical professionals. Doximity’s platform is often described as a professional network for healthcare providers, with verified physician membership representing a significant portion of licensed U.S. physicians. The company generates most of its revenue through pharmaceutical and health system marketing solutions, along with hiring and telehealth-related services.
The company’s primary business lines include digital marketing solutions for pharmaceutical manufacturers, recruitment services for healthcare organizations, and clinical productivity tools such as telemedicine, scheduling, and secure communication applications. Doximity serves pharmaceutical companies, hospitals, health systems, and medical recruiters, while also maintaining a large physician user base. Its strategic positioning is tied to its verified medical professional network, proprietary engagement data, and integration into physician workflows. Founded in 2010 by Jeff Tangney, Nate Gross, and Shari Buck, Doximity evolved from a physician networking platform into a broader healthcare digital infrastructure provider and completed its initial public offering in 2021.
Business Operations
Doximity primarily operates through a unified digital platform model rather than highly segmented industrial divisions. Its revenue is largely driven by its Marketing Solutions offerings, which provide pharmaceutical and healthcare clients with targeted digital advertising, content distribution, and physician engagement capabilities. Additional revenue streams include recruiting solutions and telehealth workflow tools used by hospitals and clinicians. The company’s products include physician networking applications, secure messaging systems, telemedicine services, scheduling and patient communication tools, and digital hiring platforms.
Operations are concentrated in the United States, where the company maintains its largest physician and healthcare institutional customer base. Doximity controls proprietary healthcare professional databases, communication infrastructure, and analytics systems tied to physician engagement. The company has also expanded capabilities through acquisitions and partnerships involving telehealth and workflow optimization technologies. Subsidiaries and acquired assets associated with productivity and digital healthcare communication initiatives have supported expansion beyond its original networking platform.
Strategic Position & Investments
Doximity’s strategic direction has focused on expanding physician workflow integration and increasing monetization of its healthcare professional network. Growth initiatives have included scaling telehealth capabilities, improving AI-assisted workflow tools, and broadening engagement products for pharmaceutical companies and healthcare systems. The company has emphasized recurring enterprise relationships with major pharmaceutical manufacturers and hospital systems while continuing to increase physician platform utilization.
The company has completed acquisitions aimed at strengthening telemedicine, scheduling, and digital communication capabilities, including the acquisition of Amion, a physician scheduling platform. Doximity has also invested in platform enhancements tied to mobile productivity, virtual patient engagement, and physician-specific AI tools. Management has consistently positioned the company as a long-term infrastructure layer for healthcare communication and professional collaboration rather than solely a social networking platform. Public filings and investor communications indicate a strategic emphasis on durable subscription and engagement-based revenue streams supported by high physician adoption rates.
Geographic Footprint
Doximity is headquartered in San Francisco, California, and its operations are primarily concentrated in the United States healthcare market. The company’s customer base includes U.S. physicians, hospitals, health systems, academic medical centers, and pharmaceutical companies. Its platform penetration among U.S. medical professionals represents one of the company’s principal competitive strengths.
While Doximity does not maintain the same degree of international operational diversification as many multinational healthcare technology firms, its services and digital infrastructure support users and institutional interactions across multiple regions connected to the U.S. healthcare ecosystem. The company’s operational influence is strongest in North America, particularly within physician communications, digital pharmaceutical marketing, and virtual care workflows.
Leadership & Governance
Doximity’s leadership team combines experience in healthcare technology, digital media, and software platform development. The company was co-founded by Jeff Tangney, who previously helped establish healthcare technology businesses prior to Doximity’s launch. Leadership communications and public filings indicate a strategic focus on physician-centric product development, workflow efficiency, and long-term platform engagement within healthcare systems.
Key executives include:
- Jeff Tangney – Chief Executive Officer and Co-Founder
- Anna Bryson – Chief Financial Officer
- Kira Scherer Wampler – Chief Marketing Officer
- Linda Hand – Vice President, People Operations
- Nate Gross, M.D. – Co-Founder and Board Member
- Shari Buck – Co-Founder and Board Member
The company’s governance structure includes a board of directors with experience across healthcare, technology, software, and finance sectors. Strategic leadership has emphasized sustainable profitability, disciplined operating expansion, and continued investment in physician engagement technologies, according to company filings and public investor communications.